Beyond Adaptive Immunity: Trained Innate Immune Responses as a Novel Frontier in Hepatocellular Carcinoma Therapy
Cancers · 07.04.2025 · 17 (7) · 1250
DOI: 10.3390/cancers17071250 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 07.04.2025. Verfasst von Ching-Hua Hsieh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chang Gung Memorial Hospital, CORPG8N0241, CMRPG8N0111.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is a leading cause of cancer death globally, with the majority of cases detected at advanced stages when curative options are limited. Current systemic therapies, including immune checkpoint inhibitors, demonstrate limited efficacy with durable responses in only 15–20% of patients. This poor response is largely attributed to HCC’s immunosuppressive microenvironment, which blunts effective T-cell responses. By illustrating that innate immune cells can acquire memory-like characteristics through a process known as trained immunity, recent evidence has challenged the conventional belief that innate immunity is devoid of memory. This review investigates the potential of trained immunity, which is defined by the long-term functional reprogramming of innate immune cells through epigenetic, transcriptomic, and metabolic changes, to provide new therapeutic opportunities for HCC. We discuss mechanisms by which trained immunity can transform the HCC microenvironment, including enhanced inflammatory cytokine production, repolarization of tumor-associated macrophages toward anti-tumor phenotypes, increased immune cell infiltration, and improved bridging to adaptive immunity. We further evaluate emerging therapeutic strategies leveraging trained immunity principles, including BCG vaccination, β-glucan administration, cytokine-trained NK cell therapy, and innovative combination approaches. Finally, we address potential resistance mechanisms and future directions for clinical application. By integrating trained immunity into conventional immunotherapeutic regimens, we may significantly improve outcomes for HCC patients, potentially transforming advanced disease into a more manageable condition.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Plastic Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.
- Department of Medical Research, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan.
- Department of General Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.
- Department of General Surgery, Kaohsiung Municipal Fong Shan Hospital-Under the Management of Chang Gung Medical Foundation, Kaohsiung 83091, Taiwan.
ORCID-Profile: Ching-Hua Hsieh
Förderung
- Chang Gung Memorial Hospital
- CORPG8N0241
- CMRPG8N0111
Zitieren
APA
Hsieh, C. H., Chuang, P. C., & Liu, Y. W. (2025). Beyond Adaptive Immunity: Trained Innate Immune Responses as a Novel Frontier in Hepatocellular Carcinoma Therapy. Cancers, 17(7), 1250. https://doi.org/10.3390/cancers17071250
Vancouver
Hsieh CH, Chuang PC, Liu YW. Beyond Adaptive Immunity: Trained Innate Immune Responses as a Novel Frontier in Hepatocellular Carcinoma Therapy. Cancers. 2025;17(7):1250. doi:10.3390/cancers17071250
BibTeX
@article{Hsieh2025,
author = {Hsieh, Ching-Hua and Chuang, Pei-Chin and Liu, Yueh-Wei},
title = {Beyond Adaptive Immunity: Trained Innate Immune Responses as a Novel Frontier in Hepatocellular Carcinoma Therapy},
journal = {Cancers},
year = {2025},
volume = {17},
number = {7},
pages = {1250},
doi = {10.3390/cancers17071250}
}
EUVIMED